Seat pricing vs consumption gap
You charge per seat while customers consume wildly different amounts of value. Consumption-priced peers grow roughly 38% faster. Every heavy user on a flat seat is margin you are giving away.
Data & analytics revenue diagnostic
Users love your data. Find why revenue lags.
Seat-versus-usage pricing, time-to-insight, unmetered expansion and trial conversion: located, priced and ranked in a written report, reviewed and signed by the founder.
7 questions · 3 minutes · no email needed to see your grade
Reviewed and signed by Waleed Alvi, PMP® · RMP®
No calls, written report
UK company 17258465
Revenue Integrity BriefIllustrative sample
NRR at 96%. Seat pricing is the wrong model.
- Pricing-model verdictSeat + usage hybrid
- NRR vs 110%+ funding bar−14 pts
- Time-to-first-insight18 days (benchmark <1 hr)
Where revenue leaks
The leaks we find most often in data & analytics companies.
Slow time-to-insight
Best-in-class data activation is under 1 hour to first insight. When time-to-value drifts past 30 days, retention collapses to the 35–50% range. Trials die before the product ever proves itself.
Unmetered expansion revenue
Your heaviest accounts would pay more as usage scales. But without consumption metering and a land-and-expand motion, that growth never shows up on the invoice.
How it works
Three steps. No meetings.
Every tier follows the same path. Only the depth of the diagnosis changes with the price.
Pick your diagnostic
Choose the tier that fits your ARR, or take the free grade first and let it point you to one.
2 minutesAnswer the intake
18 questions on pricing, retention and pipeline. Anything you don't have is flagged in the report, never guessed.
About 15 minutesGet your written report
Every leak located, priced and ranked, with the fixes in order, reviewed and signed by the founder.
18–24 hours · Starter 48–72Try it on your numbers
Estimate your leak in 30 seconds.
Four inputs, one directional estimate from published benchmarks. It is a preview, not the diagnostic.
50/100
Estimated annual recoverable
$0
Directional only. The diagnostic replaces every estimate with a figure from your own numbers.
What the diagnostic reads first
Five frameworks built for the questions data investors actually ask.
F1
Pricing-model fit
Seat, usage, or hybrid — and what does the pricing model choice do to NRR and the next raise?
F2
Usage monetization
What are your heaviest accounts actually consuming vs what they pay — and what is the seat→hybrid migration path?
F3
Retention & NRR
Where exactly is NRR leaking — slow activation, low adoption, or flat expansion — and what is the dollar repair?
F4
Time-to-insight
How long does it take a new account to reach their first insight — and what does the gap cost in retained revenue?
F5
PLG / self-serve conversion
What share of trials reach the activation event (first insight / first dashboard) before the trial window closes?
These five are read first. Each tier below states exactly how far the diagnosis goes beyond them.
Pricing
One-time price. No retainer, no calls.
Pick the tier that matches your ARR. Every diagnostic is reviewed and signed by the founder and delivered in writing.
The 3 most painful data frameworks on your real numbers — plus the SOC 2 / DPA gap-to-deal readiness map. Sharp first read before the full diagnostic. vs $15K–$50K specialist consultants charge for the SOC 2 / DPA scoping alone.
What you get
- 3 deepest data frameworks — all 18 scored
- Your total revenue-leak figure
- Usage-vs-seat monetization teardown
- Time-to-insight gap analysis
- SOC 2 / DPA gap → deal-blocking map
Seed to Series A. The full board-grade data diagnosis — seat→hybrid migration plan, activation funnel teardown, dollar-precise findings. About 0.5% of the ~$675K–$1.35M a sub-$5M-ARR data platform is typically bleeding.
1% gain ≈ up to $10K/yr at your scale
Everything in Starter, made complete
- All 18 frameworks, fully scored
- Every leak quantified in dollars
- Seat→hybrid 3-step migration plan
- 90-day roadmap + priority risk ranking
- Executive summary + health score
- PDF report, ⚡ in 18–24 hours (VIP)
Seed to Series A. The full board-grade data diagnosis — seat→hybrid migration plan, activation funnel teardown, dollar-precise findings. About 0.5% of the ~$675K–$1.35M a sub-$5M-ARR data platform is typically bleeding.
1% gain ≈ $10K–$30K/yr at your scale
Everything in Starter, made complete
- All 18 frameworks, fully scored
- Every leak quantified in dollars
- Seat→hybrid 3-step migration plan
- 90-day roadmap + priority risk ranking
- Executive summary + health score
- PDF report, ⚡ in 18–24 hours (VIP)
Series A to B. Full diagnosis plus deeper industry benchmarking — how peer data platforms compare on pricing, NRR, and activation benchmarks. About 0.5% of the ~$1.35M–$2.25M a $5M–$25M-ARR data platform is typically bleeding.
1% gain ≈ $30K–$150K/yr at your scale
Everything in Founder, plus
- A deeper, multi-pass analysis
- Cited peer benchmark-band comparisons
- Revenue recovered, modeled per fix
- Full fix backlog, ranked by impact
- 30-day written Q&A window
- PDF report, ⚡ in 18–24 hours (VIP)
Series B+. Everything in Growth, at the depth a scaling data platform needs — with an extended senior strategic debrief and priority delivery. About 0.5% of the ~$3M+ a $25M–$50M-ARR data platform is typically bleeding.
1% gain ≈ $150K–$500K/yr at your scale
Everything in Growth, plus
- Extended consumption-model analysis
- Senior written strategic debrief
- Full fix backlog with impact ranking
- Priority delivery
- PDF report, ⚡ in 18–24 hours (VIP)
Card, Apple Pay or Google Pay. Bank transfer (Wise) on Founder, Growth and Scale.Useful, or we rework it free. All sales final.Not sure which? Take the free grade first
Sample report
What you actually receive.
- Cited benchmarks
- Dollar-quantified findings
- Usage-vs-seat verdict
- Time-to-insight analysis
Format
A board-grade PDF: 22 pages for the Founder tier (5 for the Starter). Cover, exec summary, 18-framework scorecard, dollar-quantified findings, usage-vs-seat verdict, activation benchmark analysis, seat→hybrid migration plan, 30-day priority queue.
Who runs your diagnostic
Reviewed and signed by the founder.
PMP®- and RMP®-certified senior planning engineer (BEng Hons). Every diagnostic is personally run, reviewed and signed by me — no outsourced analysts, no call-booking funnel. The methodology is public: judge the teardowns before you spend a dollar.
Judge the method before you buy. Public teardowns:
Waleed AlviFounder, Intake Review · PMP® · RMP® · BEng (Hons)
- CompanyIntake Review Ltd · UK Companies House No. 17258465
- Registered office71-75 Shelton Street, London WC2H 9JQ
- How we workWritten reports only. A clarifying question comes by email, never a meeting.
- Contacthello@intakereview4500.com
- ProfileLinkedIn
Useful, or we rework it free.
If a finding doesn't hold up, a number needs sharpening or an input is missing, we rework the diagnostic at no charge until you can act on it. All sales are final; the rework is the guarantee.
Questions
What founders ask before buying.
Really no calls?
Really. Everything is async. You fill the intake, we deliver a written report. Your time stays yours. The only exception: if a finding needs a clarifying question, we ask it by email — never a meeting.
What if my metrics are incomplete?
We infer from your stage, ARR, headcount, pricing model, and time-to-insight using cited data & analytics benchmarks. Every assumption is flagged. A complete, useful diagnostic still ships — and we tell you exactly which 3 numbers to capture to upgrade it.
Is $4,500 worth it?
The average data & analytics diagnostic surfaces $300K–$800K in recoverable revenue — primarily from the seat-to-hybrid pricing gap and activation-driven churn. Consumption-priced data companies grow roughly 38% faster. We sit 4x below the cheapest boutique alternative for the same output. And if it isn't useful, we rework it free until it is.
What format is the report?
A board-grade PDF: 22 pages for the Founder tier (5 for the Starter). Cover, exec summary, 18-framework scorecard, dollar-quantified findings, usage-vs-seat verdict, activation benchmark analysis, seat→hybrid migration plan, 30-day priority queue.
How do you handle confidentiality?
Standard mutual NDA on request, sent before intake. All anonymized analysis only — no name, logo, or identifying figures leave our system. UK Ltd #17258465 means real legal accountability.
Who is this for?
B2B Data & Analytics SaaS founders, CTOs, CEOs, and Heads of Growth at $500K–$25M ARR, post-seed through Series B. If you're building a data platform, BI tool, analytics layer, or data pipeline product, this is built for your specific leaks.
Know why your revenue isn't keeping up with usage.
Start with the free grade. When you're ready, the diagnostic puts a dollar figure and a fix on every leak.